China FDA Reforms Are “Good News” For Foreign Firms … Probably
This article was originally published in The Rose Sheet
Executive Summary
Registration of imported ordinary-use cosmetics will now be administered by China Food and Drug Administration at a provincial level, which could speed the registration process, according to April Guo, regulatory affairs specialist for consulting firm CIRS’s China division. She acknowledges, however, that challenges could arise.
You may also be interested in...
PCPC Steps Up Diplomacy As China Eyes Broad Regulatory Reform
Ahead of an expected overhaul of China’s cosmetics regulations, the Personal Care Products Council is working closely with Chinese regulators, pushing for greater harmonization with regulations in the U.S. and other countries. Meanwhile, stakeholders must content themselves with piecemeal updates to China’s existing regulatory framework for cosmetics.
PCPC Steps Up Diplomacy As China Eyes Broad Regulatory Reform
Ahead of an expected overhaul of China’s cosmetics regulations, the Personal Care Products Council is working closely with Chinese regulators, pushing for greater harmonization with regulations in the U.S. and other countries. Meanwhile, stakeholders must content themselves with piecemeal updates to China’s existing regulatory framework for cosmetics.
Victor In China’s Cosmetic-Ingredient Approval Process Tells His Story
Navigating China’s notoriously challenging registration process for new cosmetic ingredients requires a local representative who can respond quickly to CFDA’s questions before the evaluation committee membership changes and sends firms back to square one. A former Symrise exec offers insight into the process and how the supplier successfully won approval for its SymWhite 377 brightening agent.